Reuters logo
BRIEF-vTv Therapeutics reports Q3 GAAP loss per share of $0.38
November 1, 2017 / 10:18 PM / a month ago

BRIEF-vTv Therapeutics reports Q3 GAAP loss per share of $0.38

Nov 1 (Reuters) - Vtv Therapeutics Inc:

* vTv Therapeutics reports third quarter 2017 financial and operational results

* Q3 GAAP loss per share $0.38

* Q3 earnings per share view $-0.41 -- Thomson Reuters I/B/E/S

* Qtrly ‍non-GAAP net loss per fully exchanged share was $0.38​

* Research and development expenses were $9.0 million in Q3 of 2017, compared to $9.6 million in Q2 of 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below